Open, non-randomised, single centre phase I study to assess the metabolism, excretion and pharmacokinetics of a single oral 100 mg dose of [14C]-AZD2281 (KU-0059436) in patients with advanced or metastatic solid tumours refractory to standard treatments

Trial Profile

Open, non-randomised, single centre phase I study to assess the metabolism, excretion and pharmacokinetics of a single oral 100 mg dose of [14C]-AZD2281 (KU-0059436) in patients with advanced or metastatic solid tumours refractory to standard treatments

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Nov 2008

At a glance

  • Drugs Olaparib (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Nov 2008 Status changed from active, no longer recruiting to completed, based on information from ClinicalTrials.gov.
    • 03 Apr 2008 Status change from initiated to recruiting, as reported by clinicaltrials.gov.
    • 31 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top